Atheroprotective Properties of Costus spicatus (Jacq.) Sw. in Female Rats
Authors:
- Bethânia Rosa LorençoneBLBethânia Rosa Lorençone
- Lucas Pires GuarnierLGLucas Pires Guarnier
- Rhanany Alan Calloi PaloziRPRhanany Alan Calloi Palozi
- Paulo Vitor Moreira RomãoPRPaulo Vitor Moreira Romão
- Aline Aparecida Macedo MarquesAMAline Aparecida Macedo Marques
- Lislaine Maria KliderLKLislaine Maria Klider
- Roosevelt Isaias Carvalho SouzaRSRoosevelt Isaias Carvalho Souza
- Ariany Carvalho dos SantosASAriany Carvalho dos Santos
- Cleide Adriane Signor TirloniCTCleide Adriane Signor Tirloni
- Nadla Soares CassemiroNCNadla Soares Cassemiro
- Denise Brentan SilvaDenise Brentan Silva
- Jane Manfron BudelJBJane Manfron Budel
Open Access
Abstract
Background: Costus spicatus (Jacq.) Sw. is a medicinal species frequently prescribed for the treatment of cardiovascular diseases. This study aims to evaluate the effects of this species against the development of atherosclerosis. Methods: First, an anatomical study of the C. spicatus leaves was performed. Then, the extract (ESCS) was obtained and submitted to phytochemical analysis. Female rats were treated with a single dose of ESCS (2000 mg/kg) to assess acute toxicity. Other groups of female rats received an atherogenic diet for 60 days. After 30 days, the animals were treated orally with ESCS (30 and 300 mg/kg), rosuvastatin (5 mg/kg), or vehicle once daily for 30 days. Serum lipids oxidized low-density lipoprotein, soluble adhesion molecules, interleukins 1β and 6, and markers of renal and liver function were measured. Renal function, blood pressure, electrocardiography, and vascular reactivity were also evaluated. Arteries, heart, liver, and kidney were also collected to evaluate the tissue redox state and histopathological analysis. Results: Prolonged treatment with ESCS induces significant hypolipidemic and antioxidant effects, that prevent endothelial dysfunction and modulated the local inflammatory process, reducing the evolution of the atherosclerotic disease. Conclusions: This study provides a scientific basis for the popular use of C. spicatus for the treatment of atherosclerosis.Keywords
Funding Information
- Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (no. 59/300.046/2015 and 71/700.135/2018)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (no. 449464/2014-8 and 407685/2018-9)
This publication has 49 references indexed in Scilit:
- Aspectos Estruturais e Fitoquímicos de partes vegetativas de Costus spicatus (Jacq.) Sw. (Costaceae)Revista Brasileira de Plantas Medicinais, 2013
- Antinociceptive and anti-inflammatory effects ofCostus spicatusin experimental animalsPharmaceutical Biology, 2010
- Costus spicatus tea failed to improve diabetic progression in C57BLKS/J db/db mice, a model of type 2 diabetes mellitusJournal of Ethnopharmacology, 2009
- Electrospray ionization tandem mass spectrometry fragmentation of protonated flavone and flavonol aglycones: a re‐examinationRapid Communications in Mass Spectrometry, 2008
- Antifungal activity of a flavonoid-rich fraction from Costus spicatus leaves against dermatophytesPlanta Medica, 2008
- ESI‐QqTOF‐MS/MS and APCI‐IT‐MS/MS analysis of steroid saponins from the rhizomes of Dioscorea panthaicaJournal of Mass Spectrometry, 2006
- Bioactive polysaccharides from Costus spicatusCarbohydrate Polymers, 2003
- Inflammation in atherosclerosisNature, 2002
- Collision‐induced fragmentation of deprotonated methoxylated flavonoids, obtained by electrospray ionization mass spectrometryJournal of Mass Spectrometry, 2001
- A New Steroidal Saponin from the Rhizomes ofCostus spicatusPlanta Medica, 1999